Common Contracts
1 similar Participant Information and Agreement contracts
PARTICIPANT INFORMATION AND AGREEMENT TO TAKE PART FORMParticipant Information and Agreement • April 12th, 2021
Universal trial number: U1111-1247-0210 EudraCT number: 2020-000299-39 Version: Final 3.0_US Official name of the study: Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in subjects with type 2 diabetes Research sponsor contact information: Novo Nordisk Inc, 800 Scudders Mill Road, Plainsboro, NJ 08536 A description of this clinical trial will be available on http://www.ClinicalTrials.gov, as required by U.S. Law. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time. Information about the study and the results will also be made available at www.novonordisk-trials.com, www.clinicaltrialsregister.eu and potentially in other regional or local registries.
